e-learning
resources
European Respiratory Review
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Therapeutic strategies in pneumonia: going beyond antibiotics
Müller-Redetzky Holger, Lienau Jasmin, Suttorp Norbert, Witzenrath Martin
Source:
Eur Respir Rev 2015; 24: 516-524
Journal Issue:
September
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Müller-Redetzky Holger, Lienau Jasmin, Suttorp Norbert, Witzenrath Martin. Therapeutic strategies in pneumonia: going beyond antibiotics. Eur Respir Rev 2015; 24: 516-524
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Update on therapeutic strategies in community-acquired pneumonia
Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice
Year: 2017
Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016
Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment
Source: Eur Respir Rev, 30 (162) 210093; 10.1183/16000617.0093-2021
Year: 2021
Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
Source: Eur Respir J 2013; 42: 1449-1453
Year: 2013
Could the initial use of antipseudomonal agents improve the prognosis for non-hospital acquired pneumonia?
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013
Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?
Source: Breathe, 17 (3) 210056; 10.1183/20734735.0056-2021
Year: 2021
Whether there are pharmacoeconomic and other advantages of using procalcitonin-guide antibacterial treatment in patients with severe community-acquired pneumonia in developing countries?
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Cost-effective antibiotic management of community acquired pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=198
Year: 2004
Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP)
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Rational use and stewardship of antibiotics in pediatric respiratory disease
Source: ERS Courses: Paediatric respiratory infections
Year: 2019
Importance of appropriate initial antibiotic therapy and de-escalation in the treatment of nosocomial pneumonia
Source: Eur Respir Rev 2007; 16: 33-39
Year: 2007
Pneumococcal pneumonia: an old disease with radically-new approaches for antibiotic therapy
Source: Annual Congress 2005 - Outcome in severe pneumonia
Year: 2005
Management of community-acquired pneumonia: new evidence-based algorithms.
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021
Are antimicrobials still the future of respiratory infection therapy?
Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections
Year: 2021
Promising prophylactic means and methods for prevention of community-acquired pneumonia and respiratory infections among servicemen in Russia
Source: Eur Respir J 2006; 28: Suppl. 50, 350s
Year: 2006
Antibiotic prescribing in acute respiratory infections – are we following guidelines?
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006
Bacterial infections and indications for treatment with antibiotics in paediatric asthma?
Source: Annual Congress 2010 - High-priority questions on airway infections in diseases seen in children and adults
Year: 2010
Corticosteroids for community-acquired pneumonia: are we still there?
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019
Pneumococcal pneumonia in hospitalized patients. Therapeutic implications of resistances to penicillin and erythromycin
Source: Eur Respir J 2003; 22: Suppl. 45, 543s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept